Search | National Guideline Clearinghouse: AMD/Low Vision Awareness Month (see related guidelines)

Search | National Guideline Clearinghouse

Health Awareness Topics: February 2017

• AMD/Low Vision Awareness Month (see related guidelines)

• GUIDELINE SUMMARY
 
• NGC:010318
 
• 1993 (REVISED 2014)

Evidence-based clinical practice guideline: eye care of the patient with diabetes mellitus.

American Optometric Association

Compare

• GUIDELINE SUMMARY
 
• NGC:009971
 
• 2013 JUL

Aflibercept solution for injection for treating wet age-related macular degeneration.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:009563
 
• 2012

Food and nutrition for older adults promoting health and wellness (FNOA).

Academy of Nutrition and Dietetics

Compare

• GUIDELINE SUMMARY
 
• NGC:010285
 
• 2014 FEB

Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:010073
 
• 2013

Occupational therapy practice guidelines for older adults with low vision.

American Occupational Therapy Association, Inc.

Compare

• GUIDELINE SUMMARY
 
• NGC:010920
 
• 2016 MAR 1

Screening for impaired visual acuity in older adults: U.S. Preventive Services Task Force recommendation statement.

U.S. Preventive Services Task Force

Compare

• GUIDELINE SUMMARY
 
• NGC:009895
 
• 2013 MAY

Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:010771
 
• 2015 JUL

Aflibercept for treating diabetic macular oedema.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:010778
 
• 2015 JUL 22

Dexamethasone intravitreal implant for treating diabetic macular oedema.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:009630
 
• 2013 APR

Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237).

National Institute for Health and Care Excellence (NICE)